TD-8236 - Theravance Biopharma
TD-8236: Data from P1 trial (NCT03652038) for asthma in mid-2020 (Theravance, Cowen & Co. 40th Annual Health Care Conference 2020) - Mar 14, 2020 - Data from P2 trial (NCT04150341) for allergen-induced asthma in 2020 or later 
P1 data • P2 data Asthma • Respiratory Diseases
http://wsw.com/webcast/cowen57/tbph/
 
Mar 14, 2020
 
 
e575bb58-124a-4f1c-83ee-797563adbfa1.jpg

4a496b4b-59e8-40a4-b5ab-157b39af1289.jpg